Tumor antigen presentation by epidermal antigen‐presenting cells in the mouse: modulation by granulocyte‐macrophage colony‐stimulating factor, tumor necrosis factor α, and ultraviolet radiation

I‐A+ epidermal antigen‐presenting cells (APCs, Langerhans cells) have been shown to present tumor‐associated antigens (TAAs) and to induce tumor immunity in vivo. This study examined the effects of ultraviolet radiation (UVR) and the cytokines granulocyte‐macrophage colony‐stimulating factor (GM‐CSF) and tumor necrosis factor α (TNF‐α) on the ability of epidermal cells (ECs) to induce or to elicit immunity against the murine spindle cell tumor S1509a. Naive syngeneic mice were immunized three times at weekly intervals with ECs that had been cultured in GM‐CSF for 18 h and then pulsed with TAA derived from S1509a. This resulted in protective immunity against subsequent tumor challenge, providing a model to study the conditions required for sensitization against TAAs by epidermal APCs. Culture of ECs in GM‐CSF was required for induction of significant protective tumor immunity, and UV irradiation or incubation in TNF‐α for 2 h after GM‐CSF incubation abrogated the immunostimulatory effect of GM‐CSF. However, unlike UVR, TNF‐α did not significantly inhibit the induction of immunity when ECs were exposed to TNF‐α before overnight incubation in GM‐CSF, together with GM‐CSF, or after pulsing with TAA, and anti‐TNF‐α antibody treatment did not abrogate the effects of UVR on this system. Furthermore, TNF‐α incubation of ECs augmented their ability to elicit delayed‐type hypersensitivity (DTH) and also enhanced elicitation of DTH by GM‐CSF–cultured ECs, whereas UV‐irradiation reduced it in a dose‐dependent fashion. Taken together, these results demonstrate that GM‐CSF, TNF‐α, and UVR are significant regulators of tumor antigen presentation by epidermal APCs and that the effects of the cytokines examined differ with regard to induction or elicitation of immunity.

[1]  R. Gallo,et al.  Regulation of GM-CSF and IL-3 production from the murine keratinocyte cell line PAM 212 following exposure to ultraviolet radiation. , 1991, The Journal of investigative dermatology.

[2]  R. Gallo,et al.  Tumor antigen presentation by murine epidermal cells. , 1991, Journal of immunology.

[3]  S. Aiba,et al.  The ability of cultured Langerhans cells to process and present protein antigens is MHC-dependent. , 1991, Journal of immunology.

[4]  A. Demidem,et al.  Comparison of effects of transforming growth factor-beta and cyclosporin A on antigen-presenting cells of blood and epidermis. , 1991, The Journal of investigative dermatology.

[5]  P. Vassalli,et al.  Tumor necrosis factor is a critical mediator in hapten induced irritant and contact hypersensitivity reactions , 1991, The Journal of experimental medicine.

[6]  K. Bendtzen,et al.  Interleukin‐6 and tumour necrosis factor alpha are expressed by keratinocytes but not by Langerhans cells , 1991, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[7]  J. Collins,et al.  Differences in the tumor necrosis factor-alpha-mediated lysis by fixed natural cytotoxic cells and fixed cytotoxic macrophages. , 1991, Journal of immunology.

[8]  T. Luger,et al.  Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light , 1990, The Journal of experimental medicine.

[9]  A. Demidem,et al.  Functional Dichotomy between Langerhans Cells that Present Antigen to Naive and to Memory/Effector T Lymphocytes , 1990, Immunological reviews.

[10]  J. Simon,et al.  Low dose ultraviolet B-irradiated Langerhans cells preferentially activate CD4+ cells of the T helper 2 subset. , 1990, Journal of immunology.

[11]  P. D. Smith,et al.  Granulocyte-macrophage colony-stimulating factor stimulates human monocyte accessory cell function. , 1990, Journal of immunology.

[12]  D. Wofsy,et al.  Effects of recombinant murine tumor necrosis factor-alpha on immune function. , 1990, Journal of immunology.

[13]  G. Schuler,et al.  Tumor necrosis factor alpha maintains the viability of murine epidermal Langerhans cells in culture, but in contrast to granulocyte/macrophage colony-stimulating factor, without inducing their functional maturation , 1990, The Journal of experimental medicine.

[14]  T. Ikejima,et al.  In situ localization of interleukin-1 in normal and psoriatic skin. , 1989, The Journal of investigative dermatology.

[15]  M. Kripke,et al.  Suppression of the elicitation of the immune response to alloantigen by ultraviolet radiation. , 1989, Transplantation.

[16]  R. Steinman,et al.  Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented best by immature, epidermal Langerhans cells , 1989, The Journal of experimental medicine.

[17]  C. Dinarello,et al.  Elevated plasma interleukin-1 levels in humans following ultraviolet light therapy for psoriasis. , 1989, The Journal of investigative dermatology.

[18]  R. Steinman,et al.  Immunologic properties of purified epidermal Langerhans cells. Distinct requirements for stimulation of unprimed and sensitized T lymphocytes , 1986, The Journal of experimental medicine.

[19]  M. Kripke,et al.  Studies on the role of antigen-presenting cells in the systemic suppression of contact hypersensitivity by UVB radiation. , 1986, Journal of immunology.

[20]  R. Steinman,et al.  Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro , 1985, The Journal of experimental medicine.

[21]  J. Streilein,et al.  Langerhans cells: antigen presenting cells of the epidermis. , 1984, Immunobiology.

[22]  J. Parrish,et al.  Ultra violet radiation-induced defects in accessory cell function in the human proliferative response to tetanus. , 1984, Clinical and experimental immunology.

[23]  R. Daynes,et al.  Effect of ultraviolet radiation on production of epidermal cell thymocyte-activating factor/interleukin 1 in vivo and in vitro. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[24]  T. Luger,et al.  The effect of in vitro and in vivo UV irradiation on the production of ETAF activity by human and murine keratinocytes. , 1983, The Journal of investigative dermatology.

[25]  H. Pehamberger,et al.  Mechanism of UV-B-induced impairment of the antigen-presenting capacity of murine epidermal cells. , 1983, Journal of immunology.

[26]  H. Hönigsmann,et al.  Ultraviolet light depletes surface markers of Langerhans cells. , 1981, The Journal of investigative dermatology.

[27]  E. Shevach,et al.  Immunologic functions of Ia-bearing epidermal Langerhans cells. , 1978, Journal of immunology.

[28]  Z. Šidák Rectangular Confidence Regions for the Means of Multivariate Normal Distributions , 1967 .

[29]  A. S. Wiener,et al.  Transplantation , 1963 .

[30]  S. Cannistra,et al.  Regulation of surface expression of the granulocyte/macrophage colony-stimulating factor receptor in normal human myeloid cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[31]  R. Granstein,et al.  Whole-body exposure to ultraviolet radiation results in increased serum interleukin-1 activity in humans. , 1987, Lymphokine research.

[32]  M. Greene,et al.  Suppressor T cells and the immune response to tumors. , 1984, Critical reviews in immunology.

[33]  N. Tommerup,et al.  Blood group substances, T6 antigen and heterochromatin pattern as species markers in the nude mouse/human skin model. , 1984, Experimental cell biology.

[34]  J. Larrick,et al.  Journal of Leukocyte Biology 45:429-433 (1989) Activated Langerhans Cells Release Tumor Necrosis Factor , 2022 .